Multiplex Assay Kit for Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) ,etc. by CBA (Cytometric Bead Array)

Flt1; Fms-Related Tyrosine Kinase 1; Vascular Permeability Factor Receptor; Fms-like tyrosine kinase 1; Tyrosine-protein kinase receptor FLT

Specificity

This assay has high sensitivity and excellent specificity for detection of Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-98 94
EDTA plasma(n=5) 80-90 84
heparin plasma(n=5) 92-101 97

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 83-93% 80-103% 78-101% 95-105%
EDTA plasma(n=5) 93-105% 95-102% 84-91% 79-101%
heparin plasma(n=5) 79-101% 78-99% 87-103% 94-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Clinical cardiology Growth Differentiation Factor 15 and Coronary Collateral Formation PubMed: 20014173
Microvascular Research Mutant hypoxia inducible factor-1α improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle PubMed: 20937289
Science Alert Antiangiogenic Activities of Cinnamon, Black and Green Tea Extracts on Experimentally Induced Breast Cancer in Rats Scialert: Source
Acta Biomater Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study PubMed: 26689470
Naunyn Schmiedebergs Arch Pharmacol The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis PubMed: 26269412
Acta Biomaterialia Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast–osteoclast–endothelial cell co-culture study Pubmed:26689470
Journal of Cellular Physiology A Human 3D In Vitro Model to Assess the Relationship Between Osteoporosis and Disseminationto Bone of Breast Cancer Tumor Cells. pubmed:27925188
Oncotarget Fasudil attenuates soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant mice through RhoA/ROCK pathway. pubmed:29262624
Placenta Modulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery. pubmed:28962687
Acta Biomaterialia Synergistic effect of Si-hydroxyapatite coating and VEGF adsorption on Ti6Al4V-ELI scaffolds for bone regeneration in an osteoporotic bone environment Pubmed: 30445158
Scientific Reports Association between Upper-airway Surgery and Ameliorative Risk Markers of endothelial function in obstructive Sleep Apnea Pubmed: 31882827
JOURNAL OF DERMATOLOGICAL TREATMENT Effect of isotretinoin (13-cis-retinoic acid) on levels of soluble VEGF receptors (sVEGFR1, sVEGFR2, sVEGFR3) in patients with acne vulgaris Pubmed: 32043381
FASEB JOURNAL Cyclin G2 upregulation impairs migration, invasion, and network formation through RNF123/Dvl2/JNK signaling in the trophoblast cell line HTR8/SVneo, a possible … Pubmed: 33205477
Children (Basel) sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates 34438609
Oxid Med Cell Longev Reactive Oxygen Species are Essential for Placental Angiogenesis During Early Gestation Pubmed:35693704
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPB818Ra02 Recombinant Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) Positive Control; Immunogen; SDS-PAGE; WB.
EPB818Ra61 Eukaryotic Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) Positive Control; Immunogen; SDS-PAGE; WB.
RPB818Ra01 Recombinant Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) Positive Control; Immunogen; SDS-PAGE; WB.
PAB818Ra01 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) WB
PAB818Ra02 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) WB; IHC; ICC; IP.
LAB818Ra83 FITC-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) WB; IHC; ICC; IF.
LAB818Ra71 Biotin-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) WB
LAB818Ra81 FITC-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) WB; IHC; ICC; IF.
MAB818Ra21 Monoclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) WB; IHC; ICC; IP.
LAB818Ra82 FITC-Linked Monoclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) WB; IHC; ICC; IF.
SEB818Ra ELISA Kit for Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB818Ra Multiplex Assay Kit for Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CMB818Ra Multiplex Assay Kit for Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.